A 58-Year-Old Man with Biochemically Recurrent Metastatic Castration-Sensitive Prostate Cancer

Marc Matrana, MD discusses the case of a man with mCSPC and reviews the current state of the mCSPC treatment landscape including both approved and emerging treatment options.